{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:41:16Z","timestamp":1789213276910,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2709,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1002\/hep.22170","type":"journal-article","created":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T15:21:05Z","timestamp":1202397665000},"page":"1264-1276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":74,"title":["Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats\u2020"],"prefix":"10.1097","volume":"47","author":[{"given":"Jonel","family":"Trebicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Leifeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hennenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Biecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Schulze","family":"Pr\u00f6bsting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20241201","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0002-9343(58)90322-X","article-title":"Circulatory changes in chronic liver","volume":"24","author":"Murray","year":"1958","journal-title":"Am J Med"},{"key":"R2-19-20241201","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2007-1007126","article-title":"Liver microvascular architecture: an insight into the pathophysiology of portal hypertension","volume":"19","author":"Ekataksin","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R3-19-20241201","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"R4-19-20241201","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0140-6736(91)91384-7","article-title":"Hyperdynamic circulation in cirrhosis: a role for nitric oxide?","volume":"337","author":"Vallance","year":"1991","journal-title":"Lancet"},{"key":"R5-19-20241201","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-1007129","article-title":"Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance","volume":"19","author":"Wiest","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R6-19-20241201","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoA\/Rho\u2010kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats","volume":"130","author":"Hennenberg","year":"2006","journal-title":"Gastroenterology"},{"key":"R7-19-20241201","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.21502","article-title":"Vascular dysfunction in human and rat cirrhosis: role of receptor\u2010desensitizing and calcium\u2010sensitizing proteins","volume":"45","author":"Hennenberg","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R8-19-20241201","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin\u2010II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Ames","year":"1999","journal-title":"Nature"},{"key":"R9-19-20241201","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1097\/00005344-200036051-00051","article-title":"Human urotensin\u2010II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate","volume":"36","author":"Douglas","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R10-19-20241201","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.bjp.0703690","article-title":"Differential vasoconstrictor activity of human urotensin\u2010II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey","volume":"131","author":"Douglas","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R11-19-20241201","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.bjp.0704051","article-title":"Depressor and regionally\u2010selective vasodilator effects of human and rat urotensin II in conscious rats","volume":"132","author":"Gardiner","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R12-19-20241201","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.bjp.0706503","article-title":"Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation","volume":"147","author":"Gardiner","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R13-19-20241201","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1291\/hypres.29.375","article-title":"Human urotensin II as a link between hypertension and coronary artery disease","volume":"29","author":"Watanabe","year":"2006","journal-title":"Hypertens Res"},{"key":"R14-19-20241201","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.bjp.0706800","article-title":"The role of urotensin II in cardiovascular and renal physiology and diseases","volume":"148","author":"Zhu","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R15-19-20241201","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/sj.ki.5000290","article-title":"Urotensin II and renal function in the rat","volume":"69","author":"Song","year":"2006","journal-title":"Kidney Int"},{"key":"R16-19-20241201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1196\/annals.1327.007","article-title":"Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation","volume":"1040","author":"Balment","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"R17-19-20241201","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/en.2003-0029","article-title":"Urotensin II is an autocrine\/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1","volume":"144","author":"Matsushita","year":"2003","journal-title":"Endocrinology"},{"key":"R18-19-20241201","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0168-8278(02)00295-7","article-title":"Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension","volume":"37","author":"Heller","year":"2002","journal-title":"J Hepatol"},{"key":"R19-19-20241201","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1478-3231.2007.01539.x","article-title":"Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension","volume":"27","author":"Kemp","year":"2007","journal-title":"Liver Int"},{"key":"R20-19-20241201","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.104.068320","article-title":"Pharmacology of the urotensin\u2010II receptor antagonist palosuran (ACT\u2010058362; 1\u2010[2\u2010(4\u2010benzyl\u20104\u2010hydroxy\u2010piperidin\u20101\u2010yl)\u2010ethyl]\u20103\u2010(2\u2010methyl\u2010quinolin\u20104\u2010yl) \u2010urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System","volume":"311","author":"Clozel","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-19-20241201","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clpt.2006.05.013","article-title":"Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients","volume":"80","author":"Sidharta","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R22-19-20241201","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/jpet.105.094821","article-title":"The urotensin\u2010II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats","volume":"316","author":"Clozel","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-19-20241201","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1365-2362.2003.01251.x","article-title":"Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats","volume":"33","author":"Heller","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"R24-19-20241201","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0002-9440(10)65427-2","article-title":"Enhanced expression of CD80 (B7\u20131), CD86 (B7\u20132), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure","volume":"154","author":"Leifeld","year":"1999","journal-title":"Am J Pathol"},{"key":"R25-19-20241201","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(92)90061-W","article-title":"Enzyme immunoassay techniques: an overview","volume":"150","author":"Porstmann","year":"1992","journal-title":"J Immunol Methods"},{"key":"R26-19-20241201","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-1759(92)90062-X","article-title":"Amplification systems in immunoenzymatic techniques","volume":"150","author":"Avrameas","year":"1992","journal-title":"J Immunol Methods"},{"key":"R27-19-20241201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho\u2010kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R28-19-20241201","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.RES.87.11.999","article-title":"Vasodilator\u2010stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide\/cGMP signaling and endothelial dysfunction","volume":"87","author":"Oelze","year":"2000","journal-title":"Circ Res"},{"key":"R29-19-20241201","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/mol.61.2.312","article-title":"Phosphorylation of blood vessel vasodilator\u2010stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide\/cyclic GMP signaling","volume":"61","author":"Ibarra\u2010Alvarado","year":"2002","journal-title":"Mol Pharmacol"},{"key":"R30-19-20241201","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/01.CIR.103.17.2188","article-title":"Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP\u2010dependent protein kinase and their downstream target vasodilator\u2010stimulated phosphoprotein in aorta","volume":"103","author":"Mulsch","year":"2001","journal-title":"Circulation"},{"key":"R31-19-20241201","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.141.2.409","article-title":"Association of the myosin\u2010binding subunit of myosin phosphatase and moesin: dual regulation of moesin phosphorylation by Rho\u2010associated kinase and myosin phosphatase","volume":"141","author":"Fukata","year":"1998","journal-title":"J Cell Biol"},{"key":"R32-19-20241201","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","article-title":"Intrahepatic upregulation of RhoA and Rho\u2010kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis","volume":"55","author":"Zhou","year":"2006","journal-title":"Gut"},{"key":"R33-19-20241201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"R34-19-20241201","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00000542-198412000-00010","article-title":"Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats","volume":"61","author":"Seyde","year":"1984","journal-title":"Anesthesiology"},{"key":"R35-19-20241201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(01)00123-1","article-title":"Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow","volume":"90","author":"Van de Casteele","year":"2001","journal-title":"Pharmacol Ther"},{"key":"R36-19-20241201","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-6363(96)88549-X","article-title":"Measurement of organ blood flow with coloured microspheres in the rat","volume":"29","author":"Hakkinen","year":"1995","journal-title":"Cardiovasc Res"},{"key":"R37-19-20241201","first-page":"G52","article-title":"Portal venous pressure and portasystemic shunting in experimental portal hypertension","volume":"257","author":"Geraghty","year":"1989","journal-title":"Am J Physiol"},{"key":"R38-19-20241201","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/hh1101.092034","article-title":"Human urotensin II\u2010induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho\u2010kinase","volume":"88","author":"Sauzeau","year":"2001","journal-title":"Circ Res"},{"key":"R39-19-20241201","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.bjp.0703513","article-title":"Human urotensin\u2010II is an endothelium\u2010dependent vasodilator in rat small arteries","volume":"130","author":"Bottrill","year":"2000","journal-title":"Br J Pharmacol"},{"key":"R40-19-20241201","doi-asserted-by":"crossref","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","article-title":"Post\u2010transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase","volume":"273","author":"Laufs","year":"1998","journal-title":"J Biol Chem"},{"key":"R41-19-20241201","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide","volume":"97","author":"Rikitake","year":"2005","journal-title":"Circ Res"},{"key":"R42-19-20241201","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-3565(24)29198-9","article-title":"Post\u2010translational control of endothelial nitric oxide synthase: why isn't calcium\/calmodulin enough?","volume":"299","author":"Fulton","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R43-19-20241201","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00323.2002","article-title":"Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase","volume":"284","author":"Fleming","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R44-19-20241201","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1053\/j.gastro.2006.12.035","article-title":"Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis","volume":"132","author":"Mookerjee","year":"2007","journal-title":"Gastroenterology"},{"key":"R45-19-20241201","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/gast.2000.8554","article-title":"Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension","volume":"119","author":"Pateron","year":"2000","journal-title":"Gastroenterology"},{"key":"R46-19-20241201","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.1840140403","article-title":"Hepatorenal reflex regulating kidney function","volume":"14","author":"Lang","year":"1991","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22170","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200804000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:41:52Z","timestamp":1737952912000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200804000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22170","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}